The Research, Scholarship, and Artistic Achievement Awards nomination deadline has been extended to May 31, 2024. Click here for more information.

Novel HIV-2 Primers and Probes


Tulane University is actively seeking commercial entities to further develop and commercialize our novel HIV-2 primers and probes.


The invention provides a novel strain of HIV-2 capable of causing immunodeficiency. The invention also provides compositions comprising the nucleic acids and polypeptides characteristic of this HIV-2 virus, antibodies specific for this HIV-2 virus, methods of using these compositions, and methods of detecting the HIV-2 virus. Can be used to detect HIV-2 virus. Can be used as therapeutics for the treatment of HIV infection. Can be used to prevent the binding of the Env protein. Can be used as part of a diagnostic kit. Can be used in immunoassay

Intellectual Property

Available For

Exclusive License in a Field
Non-exclusive License
Scientific Collaboration

For more information, please contact: